Promising Results for Anavex Life Sciences in Parkinson’s Disease Dementia Study
Anavex Life Sciences has reported encouraging findings from the extended phase 2 study of its investigational drug, ANAVEX2-73, also known as blarcamesine, in patients suffering […]